期刊
DRUG DISCOVERY TODAY
卷 17, 期 9-10, 页码 443-450出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2012.01.006
关键词
-
资金
- US National Institutes of Health [NIGMS 73042]
- Robert A Welch Foundation [I-1244]
- CHDI Foundation
- McKnight Foundation
Expanded trinucleotide repeats cause Huntington's disease (HD) and many other neurodegenerative disorders. There are no cures for these devastating illnesses and treatments are urgently needed. Each trinucleotide repeat disorder is the result of the mutation of just one gene, and agents that block expression of the mutant gene offer a promising option for treatment. Therapies that block expression of both mutant and wild-type alleles can have adverse effects, challenging researchers to develop strategies to lower levels of mutant protein while leaving adequate wild-type protein levels. Here, we review approaches that use synthetic nucleic acids to inhibit expression of trinucleotide repeat genes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据